Dengue encephalitis (DE) is characterized as unusual presentation of dengue infection. 27 Despite the reports that DE accounts for only 1% to 5% of dengue cases, this disease tends to 28 be increasingly reported to threaten global human health throughout dengue endemic areas 29 particularly in Southeast Asia. The molecular information of clinically characterized, 30 neurotropic dengue virus (DENV) in human beings is extremely scarce despite it playing an 31 important role in deciphering the pathogenesis of dengue-related neurological cases. Here we 32 report a case of DE caused by DENV3 genotype III in a male patient with atypical symptoms 33 of DENV infection in Hai Phong, Vietnam in 2013. The virus isolated from the cerebrospinal 34 fluid of this case-patient was closely related to DENV3 genotype III strains isolated from 35 serum of two other patients, who manifested classical dengue in the same year and residing in 36 the same area as the case-patient. It is noteworthy to mention that in 2013, DENV3 genotype 37 III was detected for the first time in Vietnam. 38 39 40 41 42 43 44 45 46 47 48
predominantly in endemic countries of Southeast Asia (1-6). These unusual presentations 57 have been classified as severe dengue cases (7) , however, the neuropathogenesis of DENV 58 infection is still poorly understood (8). Previously, neurologic manifestations were considered 59 as the consequences of an encephalopathy secondary to prolonged shock, hyponatraemia, 60 hepatic failure or intracranial bleeding rather than encephalitis because of the failure to 61 demonstrate the presence of DENV in the CNS (9, 10) . Since the 1990s, the concept of 62 DENV neurotropism was noticed and the number of reports on dengue patients with virus 63 isolation from CSF or brain tissue has risen (10, 11 Neurological examination did not show any focal neurological deficits apart from neck 78 stiffness. Laboratory tests showed normal range in hemogram with slight increase in C -79 reactive protein (Table 1) . CSF analysis revealed 10 white blood cells (WBC)/mm 3 but there 80 was no information relating to protein, sugar and lactate (Table 1) . A provisional diagnosis of 81 suspected meningoencephalitis was made and the patient was given an empiric antibiotic 82 treatment (Rocephin -the 3 rd generation cephalosporin antibiotic) in view of the possibility 83 of bacterial infection. Despite this treatment, his symptoms were not improved, therefore, he 84 was transferred to the referral hospital on day 3 of disease onset. In this hospital, leukopenia 85 was noted in the laboratory tests; CSF analysis revealed 8 WBC/mm 3 and slight increase in 86 protein concentration (Table 1) . Treatment was continued with the 3 rd generation of 87 cephalosporin antibiotic (Ceftriaxon) and analgesic. Occasionally, the patient was prescribed 88 with oral sedative (Seduxen) to control the irritation due to severe headache. On day 6 of 89 disease onset, hemogram showed continuous leukopenia associated with mild 90 thrombocytopenia and dengue serology (SD BIOLINE Dengue Duo kit) was positive for 91 anti-dengue IgM and IgG antibodies. Additionally, the patient started to feel improvement 92 from the symptoms of fever and headache simultaneous with the appearance of 93 maculopapular rash. On day 9 of disease onset, hemogram indicated a normalization of 94 leukocyte and platelet counts ( Table 1) . The patient was discharged after 9 days of 95 hospitalization without any neurological sequelae.
96
Following these results, a CSF specimen of this patient collected on day 1 of disease 97 onset in Viet tiep's hospital was retrospectively analyzed. In this CSF sample, although the 98 presence of anti-dengue IgM antibodies was negative by the in-house ELISA test, the 99 presence of DENV RNA was confirmed by reverse transcriptase polymerase chain reaction 100 5 (RT-PCR) and DENV3 was successfully isolated ( (12), neurological cases due to DENV3 have been increasingly reported in 109 recent years worldwide (1, 5, 10, 13, 14) . In the southern part of Vietnam, there was one 110 study that described the phylogenetic relationship between CSF-derived DENV2 and serum-111 derived DENV2 from the same DE patient (14), however, there are no published data on 112 DENV3 genotype III infecting a patient with neurological manifestation. 
Discussion

115
Dengue encephalitis has been noticed as an unusual presentation with the prevalence 116 being estimated to occur in 1% to 5% of dengue cases (8). Neurologic manifestations caused 117 by DENV can occur in a patient at the age of few months to 79 years and more frequently in 118 children (8). The median time for onset of CNS symptoms was reported to be 3 to 7 days 119 from the onset of fever (1, 4) . Interestingly, Soares et al (2006) reported the existence of CNS 120 involvement for longer period ranging between 4 to 30 days with a median time of 12 days 121 after the onset of the fever among 13 patients aged 11 to 79 years (15) . Surprisingly, the 122 presented case showed CNS symptoms on day 1 of the onset of fever.
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In comparison to other dengue serotypes, DENV2 and DENV3 tend to have the highest 124 propensity to neurological complications whether in primary or secondary infections (1, 4) . : 60% polymorphs and 40% lymphocytes 
